Iodine-123 MIBG imaging before treatment of heart failure with carvedilol to predict improvement of left ventricular function and exercise capacity

Journal of Nuclear Cardiology

Volumn 8, Issue 1, 2001, Pages 4-9

  Choi, Joon Young ^a   Lee, Kyung Han ^a   Hong, Kyung Pyo ^a   Kim, Byung Tae ^a   Seo, Jung Don ^a   Lee, Won Ro ^a   Lee, Sang Hoon ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Carvedilol; Congestive heart failure; Iodine 123 metaiodobenzylguanidine; blockade

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; CAPTOPRIL; CARVEDILOL; DIGOXIN; FUROSEMIDE; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; EXERCISE; FEMALE; HEART; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HUMAN; MALE; MEASUREMENT; MEDIASTINUM; OXYGEN CONSUMPTION; PREDICTION; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; STATISTICS; SYMPATHETIC TONE; TIME; TREATMENT OUTCOME;

EID: 0035085077     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1067/mnc.2001.109452     Document Type: Article

References (13)

1. Cardiac sympathetic neurotransmission scintigraphy
2. Use of iodine-123 metaiodobenzylguanidine myocardial imaging to predict the effectiveness of beta-blocker therapy in patients with dilated cardiomyopathy
3. Iodine-123 metaiodobenzylguanidine myocardial scintigraphy for prediction of response to beta-blocker therapy in patients with dilated cardiomyopathy
4. 123I meta-iodobenzylguanidine imaging in predicting the effectiveness of beta blockers for patients with idiopathic dilated cardiomyopathy before and soon after treatment
5. Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart
6. Comparison of high- and low-intensity exercise training early after acute myocardial infarction
7. Effects of carvedilol on left ventricular mass, chamber geometry, and mitral regurgitation in chronic heart failure
8. Carvedilol prevents remodeling in patients with left ventricular dysfunction after acute myocardial infarction
9. Comparison and reproducibility of visual echocardiographic and quantitative radionuclide left ventricular ejection fractions
10. Comparison of different echocardiographic methods with radionuclide imaging for measuring left ventricular ejection fraction during acute myocardial infarction treated by thrombolytic therapy
11. Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy
12. Carvedilol, a new vasodilating beta-adrenoceptor blocker, inhibits oxidation of low-density lipoproteins by vascular smooth muscle cells and prevents leukocyte adhesion to smooth muscle cells
13. Carvedilol inhibits endothelin-1 biosynthesis in cultured human coronary artery endothelial cells